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Disease presentation and clinical course in black, 
coloured and white Crohn’s disease patients in the 
Western Cape, South Africa
A Basson
University of the Western Cape, Cape Town, South Africa
Objective. To describe the clinical disease course of black, coloured 
and white Crohn’s disease (CD) patients from the gastrointestinal 
clinics of the Groote Schuur and Tygerberg hospitals.
Methods. Disease phenotype was described in consecutive CD 
patients diagnosed prior to 2006, using scheduled appointment lists 
from September 2011 to March 2013. Seven black, 152 coloured and 
35 white cases were identified. Patients with history of tuberculosis 
or amoebiasis were excluded. Age of onset, disease location, disease 
behaviour, surgical intervention, presenting symptoms, extraintestinal 
manifestations (EIM), smoking, and family history of inflammatory 
bowel disease (IBD) was assessed.
Results. Of the black patients, 5 had ileocolonic (71%), 1 had ileal 
(14%), 1 had colonic (14%) involvement, no family history of IBD 
was reported, and 6 were smokers at diagnosis. Perianal disease 
was present in all except 2 ileocolonic patients. At diagnosis, 43% 
required surgical intervention and 71% had fistulising disease. All 
black cases had EIMs. Of the coloured patients, ileocolonic (56%) and 
colonic (26%) involvement was most common with 55% requiring 
surgical intervention at diagnosis. Coloured patients presented with 
a younger median age of onset (26 years; interquartile range 18 - 
33), by approximately 4 years, with higher prevalence of multiple 
presenting symptoms, compared with white and black cases. Of the 
white patients, ileal (43%) and ileocolonic (40%) involvement were 
most common and 48% required surgical intervention at diagnosis.
Conclusions. Preliminary analysis suggests that ileocolonic involvement 
is most common between races; however, coloured patients have the 
highest proportion of surgical intervention at diagnosis and appear to 
be diagnosed younger, with more presenting symptoms.
Prediction of treatment outcomes from 
manometric subtypes in achalasia patients
S Botha, S Hlatshwayo, P Bornman, S Thomson, S Gabriel, 
G Watermeyer
University of Cape Town, Cape Town, South Africa
Background. There is emerging evidence that suggests that response 
to achalasia therapy is influenced by the manometric subtype 
obtained by high-resolution manometry (HRM). 
Objective. To evaluate the usefulness of manometric subtypes in 
predicting outcome of treatment.
Methods. HRM data were collected in all newly diagnosed achalasia 
patients prior to treatment with either pneumatic balloon dilatation 
(PBD) or laparoscopic Heller’s myotomy (LHM). The manometric 
tracings were then classified into the 3 Chicago subtypes by an 
experienced physician. Dysphagia symptoms (recorded as Eckardt 
scores) were also documented before and after treatment.
Results. Nine of the 31 patients had achalasia type 1 (29%), 21 had 
type 2 (68%) and only 1 had type 3 (3%). The median follow-up time 
was 8 months (interquartile range 5 - 15). The success rate was 67% in 
subtype 1, 76% in subtype 2 and 100% in subtype 3 (only 1 patient). 
Overall, the success rate was 74% and the difference between PBD 
and LHM was not statistically significant (PBD 76% v. LHM 67%; 
p=0.890).
Conclusion. There is a pattern towards better outcome in those with 
type 2 manometric phenotype than those with type 1. However, 
the patient numbers in this study were too small to make firm 
conclusions.
Endoscopic ultrasound in the drainage of symptomatic 
pancreatic and peri-pancreatic fluid collections
S Burmeister, D Levin, S Thomson
University of Cape Town, Cape Town, South Africa
Background. Endoscopic drainage has been shown to be a safe 
and effective means of draining symptomatic pancreatic and peri-
pancreatic fluid collections occurring as a result of both acute 
and chronic pancreatitis. Its use, however, may be limited by both 
technical and patient-related factors. The development of endoscopic 
ultrasound has been purported to facilitate the endoscopic drainage 
of such collections as well as reduce complications.
Objectives. This single-centre prospective study evaluated our initial 
experience with this modality in the management of these collections.
Methods. Between February 2011 and May 2013, 31 patients (18 men, 
13  women; mean age 42.2 years; range 11 - 77) with symptomatic 
pancreatic or peri-pancreatic fluid collections, occurring as a 
complication of acute (n=23) or chronic pancreatitis (n=8), were 
considered for endoscopic drainage on the basis of findings on 
computed tomography (CT) or magnetic resonance imaging (MRI).
Results. The pancreatic/peri-pancreatic fluid collection was successfully 
accessed in 31 patients (100%). Twenty-three (74%)  patients 
underwent placement of 1 or more plastic pigtail stents, 3  (10%) 
had placement of a removable, covered self-expanding metal stent, 
3 (10%) were managed with aspiration only and 2 (6%) patients 
could not be endoscopically drained and proceeded to surgical 
drainage, post endoscopic procedure. Three patients developed delayed 
complications relating to endoscopic drainage and required surgical 
intervention: development of sepsis within a residual collection (n=1), 
delayed gastrointestinal perforation related to an endoscopically placed 
plastic stent (n=1) and migration of a self-expanding metal stent into a 
partially drained cavity (n=1). Endoscopic management was successful 
in 26 (84%) patients. Two  patients developed pneumoperitoneums 
following endoscopic intervention, but were successfully managed 
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conservatively with bowel rest and antibiotics. There were no instances 
of early, clinically significant bleeding or gastrointestinal perforation 
related to the procedure.
Conclusion. Endoscopic ultrasound facilitates safe and effective, 
minimally invasive management of pancreatic and peri-pancreatic 
fluid collections occurring as a result of either acute or chronic 
pancreatitis.
The sero-prevalence of hepatitis C infection in an HIV-
infected male population of heterosexual and men who 
have sex with men (MSM) in Cape Town
N Gogela,1,2 M Sonderup,1 K Rebe,3 W Spearman1
1  Division of Hepatology, University of Cape Town and Groote Schuur 
Hospital, Cape Town, South Africa
2  GIT Clinic, University of Cape Town and Groote Schuur Hospital, 
Cape Town, South Africa
3  Health4Men Clinic, Anova Health Institute, Cape Town, South Africa
Background. Hepatitis C virus (HCV) is a significant health problem 
with over 3% of the world’s population infected. Transmission is 
mostly through parenteral routes via needles or exposure to blood 
products pre-1990. Heterosexual transmission is uncommon, but 
men who have sex with men (MSM) have an elevated risk of 
acquiring both HIV and HCV. The estimated local prevalence of 
HCV is 0.3% - 1% while in Western Cape blood donors it is <0.3%. 
Co-infection rates among MSM who are injecting drug users in 
Europe and the USA are high; however, local prevalence is unknown.
Methods. A prospective study was initiated and confirmed HIV-
positive patients were recruited from various hospitals and clinics 
around Cape Town, including a dedicated MSM clinic. All patients 
were ≥18 years old and those who consented completed a confidential 
questionnaire surveying risk stratification, sexual orientation, blood 
transfusion pre-1990 and drug use. All were screened for HCV.
Results. To date, 168 male patients have been recruited, 51% (n=86) MSM 
and 49% (n=82) heterosexual (mean age 38.9, standard deviation (SD) 
±7.9 years and 39.0±7.8 years). Ethnically, in the MSM and heterosexual 
group 75% v.15% were white; 16% v. 77% were black and 8% v. 7% were 
of mixed ancestry. Overall 6% (n=10) tested HCV antibody positive, all 
from the MSM cohort, representing 12% of this group. All HCV-positive 
patients had a history of prior or current drug use.
Conclusion. These interim results suggest that our local HCV 
prevalence in HIV-positive patients is underestimated, risk seems to 
be limited to the MSM sub-group. Targeted routine HCV testing is 
this group may be warranted.
Oesophageal cancer in Pietermaritzburg: The shocking 
timeline to diagnosis and definitive management
M Govender1,2
1  Nelson Mandela School of Medicine, University of KwaZulu-Natal, 
Durban, South Africa
2  Greys Hospital, Pietermaritzburg, South Africa
Background. Despite advances in management, oesophageal cancer 
remains a disease with dismal outcomes. Most patients present with 
advanced lesions amenable only to palliation. 
Objective. To quantify the oesophageal cancer timeline, from first 
symptom to definitive management, and to identify undue delays and 
points of potential impact. 
Methods. This was an audit of patients seen with oesophageal 
cancer at Greys Hospital in Pietermaritzburg from January to 
November  2012. Patients were identified from records at oncology 
and surgical clinics and the gastrointestinal unit. A retrospective 
analysis of records was performed and a timeline plotted, which 
included duration of symptoms prior to first presentation, and time 
to diagnosis and to definitive management. 
Results. A total of 113 patient charts were reviewed. The time to 
first visit ranged from immediate presentation to a 12-month delay, 
with the average symptom duration being 5  months. Establishing 
a diagnosis took an average of 1 month from first presentation but 
varied from 0 to 8 months. Once a patient was diagnosed, definitive 
management was instituted on average 1 month later (range 0 - 
7  months). The overall timeline from first symptom to definitive 
management was 2 - 14 months (mean 7). 
Conclusion. There are unacceptably long delays in the presentation, 
diagnosis and management of oesophageal cancer in our environment. 
The problem is multifaceted. Patient education and improved referral 
systems may result in earlier presentation. The use of protocols 
and a multidisciplinary team may facilitate rapid diagnosis and 
management. Only by significantly reducing delays can we hope to 
affect outcomes.
Pneumatic balloon dilatation v. laparoscopic Heller 
myotomy: A teaching hospital experience
S Hlatshwayo, S Botha, P Bornman, S Thomson, G Chinnery, 
G Watermeyer, D Levin
University of Cape Town, Cape Town, South Africa
Background. Even though the European Achalasia Trial showed that 
pneumatic balloon dilatation (PBD) was as good as laparoscopic 
Heller myotomy (LHM) in primary achalasia, many healthcare 
professionals still consider LHM to be superior to PBD. 
Objective. To compare the two treatment modalities in a cohort of 
patients treated in a teaching hospital.
Methods. Prospectively collected data from newly diagnosed 
achalasia patients managed by LHM and PBD were analysed. 
Symptoms of achalasia were documented using Eckardt scores 
(derived from the symptoms of weight loss, dysphagia, chest pain 
and regurgitation). The primary outcome was effective relief of 
symptoms, defined as an Eckardt score <3 and/or the need for 
alternative treatment. The secondary outcome was the complication 
rate in the two arms.
Results. Seventy-two of a total of 112 patients (64%) had PBD while 
the remaining 40 (36%) had LHM. The median follow-up period 
was 34 months (range 2 - 116). Therapeutic success rate in the LHM 
arm was 75% (30/40) v. 67% (48/72) in the PBD arm. The differences 
between the two treatment modalities were not statistically different 
(p=0.717). There were 2 perforations (3%) following PBD and 
2  patients (5%) had mucosal breach during LHM. There were 
no deaths related to the procedures. One patient had aspiration 
pneumonia and another had minor wound sepsis in the LHM group.
Conclusion. Pneumatic balloon dilatation was found to be equivalent 
in efficacy to LHM in patients with newly diagnosed achalasia. The 
complication rate was low in both groups.
Comparison of the diagnostic yield and clinical 
outcomes of an approach based on initial double 
balloon enteroscopy v. initial capsule endoscopy 
in patients with obscure gastrointestinal bleeding
E Kamau, S Thomson
University of Cape Town, Western Cape, South Africa
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Objective. To describe the diagnostic yield and clinical outcomes 
of a strategy based on initial capsule endoscopy followed by double 
balloon enteroscopy v. the use of double balloon enteroscopy alone in 
the management of obscure gastrointestinal bleeding.
Methods. This was a retrospective descriptive study of the medical 
records of 26 patients who had double balloon enteroscopy alone and 
35 patients with initial capsule endoscopy followed by double balloon 
enteroscopy at the Groote Schuur Hospital between May 2009 and 
April 2013.
Results. Occult gastrointestinal bleeding was the primary indication 
for subsequent procedure in 81% of patients who underwent double 
balloon enteroscopy alone and in 51% of the patients who had initial 
capsule endoscopy. Of patients with double balloon enteroscopy 
alone, 61.5% (n=16) had positive findings. The small bowel findings 
included angiodysplasia (n=6), tumours (n=3) and ulcers (n=4). Argon 
plasma photocoagulation was successfully applied in all patients with 
angiodysplasia and biopsies taken in the patients with tumours. In 
the group who had initial capsule endoscopy, the diagnostic yield was 
77.1% (n=27) with capsule endoscopy and 71.4% (n=25) with double 
balloon enteroscopy (p=0.157); 74.6% of the findings correlated 
positively. The most common finding was angiodysplasia and argon 
plasma coagulation (APC) was applied successfully in all cases. The 
clinical outcomes at 6 months were favourable in 46.1% and 60% of 
patients with double balloon enteroscopy alone and initial capsule 
enteroscopy, respectively (p=0.016).
Conclusion. Capsule endoscopy improved the diagnostic yield of 
double balloon enteroscopy by 10% and this resulted in significantly 
better short-term clinical outcomes.
A prospective review of the endoscopic management of 
large bile duct calculi using controlled radial expansion 
(CRE) balloon dilatation v. sphincterotomy
E Loots, S Rambarran, F Anderson
Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Natal, 
Durban, South Africa
Background. Choledocholithiasis can present with varying sizes, number 
of calculi and associated complications. Endoscopic techniques allow for 
early interventions and less invasive surgery. 
Objective. This study examines the techniques used in the management 
of large bile duct calculi.
Methods. All patients presenting for an endoscopic retrograde chol-
angiopancreatography (ERCP) were prospectively examined from June 
2011 to May 2013 in a single unit. Information was collected where bile 
duct calculi were >9 mm. Demographic information, haematological 
results and radiological investigations were collected. The type of 
endoscopic intervention, outcome and subsequent management were 
documented. Comparison was made between the sphincterotomy 
group and controlled radial expansion (CRE) balloon dilatation group. 
The χ2 test was used for categorical data and the Student’s t-test for 
continuous data in the statistical analysis.
Results. A total of 270 ERCPs were performed between June 2011 and 
May 2013. Forty-five patients were identified, comprising 13 males and 
33 females. Five patients had prior magnetic resonance cholangiography 
(MRCP) and 2 had endoscopic ultrasound. Fifty-two ERCP procedures 
were performed. Twenty-seven patients had CRE dilatation and 18 
sphincterotomy. There was a statistical difference between albumin 
and alkaline phosphatase (ALP) levels, but it was not noted with 
bilirubin, γ-glutamyltransferase (GGT), alanine transaminase (ALT), 
haemoglobin and international normalised ratio (INR). The average 
number of calculi was 6 with an average size of 16 mm. Endoscopic 
failure was noted in a third of patients. The sphincterotomy group 
had 3 complications: a pancreatitis, retroperitoneal perforation and a 
lodged Dormia basket. There were no procedure-related complications 
in the CRE group reaching statistical significance.
Conclusion. Endoscopic therapy is effective in the majority of large 
choledocholithiasis. The use of CRE balloon sphincterotomy greatly 
facilitates ductal clearance and reduces procedure-related complications. 
MRCP remains underutilised as a non-invasive investigation in a 
resource-constrained environment.
Solitary extramedullary plasmacytoma of the colon, 
rectum and anus: A collective review
M Mjoli,1,2 N Vorajee,1 J Howlett,1,2 T Madiba1
1  Pietermaritzburg Hospital Complex, Pietermaritzburg, South Africa
2  University of KwaZulu-Natal, Durban, South Africa
Objective. To determine treatment characteristics and clinical outcomes 
of patients with solitary extramedullary plasmacytoma (SEP) of the 
colon, rectum and anus.
Methods. A systematic literature search was performed to identify 
all case reports and series on SEP of the colon, rectum and anus. A 
single case treated at our institution was added to these case reports. 
All multiple myeloma cases were excluded. Patient characteristics, 
treatment, and outcomes of each patient were entered in a database 
and a pooled analysis was carried out.
Results. Twenty-eight patients were identified with a mean age of 53.5 
years. Males were more common, with a male:female ratio of 3:1. The 
common symptoms were pain (n=14), rectal bleeding  (n=8), and 
constitutional symptoms (n=7). The most common sites of colonic 
involvement were sigmoid colon (n=9), caecum (n=8) and rectum (n=5). 
The most common surgical intervention was segmental colectomy. 
Treatment was more variable where the rectum was involved and 
consisted of endoscopic resection, radiotherapy and rectal resection. 
Twenty-six patients had a curative resection with 2 locoregional 
recurrences. Follow-up was documented in 18/28 patients. The mean 
duration of follow-up was 13.9 months.
Conclusion. Solitary extramedullary plasmacytoma is rare and 
commonly affects the caecum and sigmoid colon. No conclusions 
can be drawn regarding the optimal management and their outcomes. 
However, this review may help the surgeon with the available 
management options to consider.
The impact of biological therapy in patients with 
inflammatory bowel disease at Groote Schuur Hospital
A Rajula, S Thomson, G Watermeyer
University Of Cape Town, Cape Town, South Africa
Objectives. To audit the use of biologicals in patients with 
inflammatory bowel disease (IBD).
Methods. A retrospective analysis of IBD patients treated with biologicals 
(from 2009 to 2013) was performed. Relevant data pertaining to 
demographics, disease characteristics, concomitant medications and 
response were entered into a database and analysed.
Results. A total of 24 patients were available for analysis (mean age at 
diagnosis 28.6 years, standard deviation (SD) ±12.2), 67% were male. 
The median duration of disease prior to biologicals was 66 months 
(interquartile range 20 - 120). The majority were of mixed ancestry 
(54%) and 59% were smokers. There were only 4  patients with 
ulcerative colitis (UC), all treated with infliximab for acute, severe 
UC. All responded well and avoided colectomy. Of the cohort (20/24), 
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83% had Crohn’s disease (CD); of these 25% had ileocaecal disease, 
30% isolated colonic CD and 45% ileocolonic CD. Only 20% (4/20) 
had inflammatory (non-fistulising, non-penetrating CD) at the time 
of biological initiation, while 15% had a stricturing phenotype and 
65% penetrating CD; 45% had perianal disease. Infliximab (IFX) and 
adalumimab were given in 55% and 45%, respectively, and 95% were 
receiving concomitant immunomodulators (19/20), 17 of these were 
receiving azathioprine. Only 40% of patients with CD had a primary 
response. None of the baseline variables significantly predicted this 
outcome on univariate analysis.
Conclusion. While IFX is of value in UC as colon salvage therapy, 
we report disappointing primary response rate in our cohort with 
CD. This likely reflects the introduction of these agents in advanced 
complicated CD when irreversible damage has already occurred. 
While none of the baseline variables significantly predicted primary 
response, our sample size is likely too small for meaningful analysis.
Triad of dysregulated signalling in human 
hepatocellular carcinoma suggests a multipronged 
approach is needed for therapeutic targeting
M Setshedi,1,2 L Longato,2 K Ripp,2 W Chen,2 Q-G Nguyen,2 J Wands,2 
S de la Monte2
1  University of Cape Town, Cape Town, South Africa
2  Warren Alpert Medical School, Brown University, Providence, USA
Background. Previous studies highlighted potential roles of aberrant 
activation of insulin/insulin receptor substrate (IRS), canonical Wnt/β-
catenin, or Notch/Jagged/aspartyl-(asparaginyl)-β-hydroxylase (AAH) 
as mediators of hepatocellular carcinoma (HCC) pathogenesis or pro-
gression. In addition, a role for pro-inflammatory mediators of cell 
injury, turnover, and DNA damage is under investigation in HCC 
development. 
Objective. We examined the extent to which each of these pathways 
were upregulated in HCC v. peri-tumour liver tissue, and evaluated the 
potential contributions of pro-inflammatory cytokines as mediators of 
progressive liver injury. 
Methods. Paired surgically resected HCCs (n=8) and tumour-free peri-
HCC livers (n=8) were used to measure gene expression by quantitative 
reverse transcription-polymerase chain reaction (qRT-PCR), and 
immunoreactivity by either multiplex or duplex enzyme-linked 
immunosorbent assays (ELISAs). 
Results. Insulin: HCC was associated with significantly upregulated 
expression of the insulin-like growth factor (IGF) 2 receptor, insulin 
receptor substrate (IRS) 1, IRS2, and IRS4 genes, increased signalling 
through IGF-1R (p=0.001) and IRS1 (p=0.015), and inhibition of 
glycogen synthase kinase (GSK)-3β activity relative to peri-tumour 
liver tissue. Wnt/β-catenin: HCCs had significantly increased mRNA 
expression of Wnt 3 (p<0.0001), Wnt5A (p=0.004), and Wnt5B (p=0.01) 
ligands, and frizzled-6 receptor (p=0.02), and decreased expression of 
secreted frizzled related protein (FRP) 1 (p=0.01) and sFRP5 (p=0.008) 
relative to peri-tumour tissues. Notch: HCCs had significantly increased 
expression of AAH, Humbug, Notch-1, Jagged-1, and hairy and enhancer 
of split-1 (HES-1) relative to peri-tumour tissues. Inflammation: 
multiplex ELISAs used to measure 24 different cytokines/chemokines, 
demonstrated increased expression of only interferon (IFN)-γ, and 
significantly reduced levels of interleukin (IL)-1β, IL-6, tumour necrosis 
factor (TNF)-related apoptosis-inducing ligand (TRAIL), MIP-1 and 
β-nerve growth factor (NGF) in HCC relative to peri-tumour liver tissue. 
Conclusions. HCCs are associated with simultaneous dysregulation 
of 3 major signalling pathways that likely cross-talk through various 
mechanisms, including GSK-3β. The prominent down-regulation 
of several pro-inflammatory cytokines suggests that compromised 
host surveillance mechanisms rather than inflammation-mediated 
cell injury may contribute to the pathogenesis or progression of 
HCC. Altogether, the data suggest that effective therapeutic targeting 
of HCCs will require multipronged approaches that abrogate 
dysregulation of the insulin/IRS, Wnt/β-catenin, and Notch pathways 
and fortify host immune surveillance mechanisms.
Characteristics of hepatitis B-associated hepatocellular 
carcinoma (HCC) in Cape Town
M Sonderup, M Setshedi, W Spearman
Division of Hepatology, University of Cape Town and Groote Schuur 
Hospital, Cape Town, South Africa
Objective. Globally, hepatocellular carcinoma (HCC) is the 6th most 
prevalent cancer with 75% occurring in Southeast Asia and sub-
Saharan Africa due to the endemicity of hepatitis B virus (HBV).
Methods. Prospectively since 2011, patients presenting to Groote 
Schuur Hospital with HCC where HBV was assessed as being the 
likely risk factor, were recruited. Patients were excluded if they had 
hepatitis C co-infection or alcohol as a dominant risk factor. Patient 
demographics, HBV characteristics, HCC features and other relevant 
data were recorded.
Results. Thirty-three patients – 52% (n=17) black, 36% (n=12) 
mixed ancestry and 12% (n=4) white – were evaluated (mean age 
43.2, standard deviation (SD) ±11.9 years). Males predominated 
(85%, n=27) and 15% (n=5) were HIV co-infected, median CD4+ 
count was 250 cells/μl (range 216 - 567). Five patients were HBsAg-
negative but heterogeneous hepatitis B (HB) core IgG-positive, 
1  having detectable HBV DNA. Of those HBsAg-positive, 32% 
(n=9) were HBeAg-positive, 68% (n=19) HBeAg-negative, with 
mean ±SD HBV viral loads of 6.2±1.5 and 4.5±2.3 log copies/ml, 
respectively (p=0.03). The median α-fetoprotein (α-FP) was 4 091 
μg/l (range 2.9 - 401  986) with only 12% (n=4) having normal 
α-FP levels. In terms of liver function at presentation, median total 
bilirubin, albumin and international normalised ratio (INR) were 
22 μmol/l (range 6 - 300), 29 g/l (range 16 - 48 g/l) and 1.32 (range 
0.99 -3.17); respectively. Interestingly, median alanine transaminase 
(ALT)(61  U/l; range 22 - 378) and aspartate transaminase (AST) 
(118 IU/l; range 23 - 1156) differed significantly (p=0.0009). The 
majority, 64% (n=21), had multicentric HCC, 27% (n=9) with focal 
and 9% (n=3) with diffusely infiltrating tumour. Histologically 
(n=16), 75% (n=12) had established cirrhosis while the majority, 
56% (n=9) had poorly differentiated HCC. To date median survival 
is 4 months (range 1 - 24).
Conclusion. HBV-associated HCC continues to carry a poor prognosis 
with patients presenting late with essentially incurable disease. α-FP 
remains a useful tumour marker.
Randomised clinical trial: Effect of Lactobacillus plantarum 
299v on symptoms of irritable bowel syndrome
C Stevenson,1 R Blaauw,1 E Fredericks,2 J Visser,1 S Roux2
1  Stellenbosch University, Cape Town, South Africa
2  Nelson Mandela Metropolitan University, Port Elizabeth, South Africa
Background. Irritable bowel syndrome (IBS) is the most common 
diagnosis in gastroenterology. Its aetiology is unknown and 
therapeutic options are limited. Consensus guidelines and results 
from systematic reviews suggest that probiotics may be beneficial, 
although controversy still exists.
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Objective. To assess the symptomatic efficacy of Lactobacillus plantarum 
299v for the relief of abdominal pain in patients with IBS fulfilling 
Rome II Criteria.
Methods. In this double-blind, placebo-controlled, parallel-
designed trial participants were randomised to receive daily either 
2 capsules of L. plantarum 299v or a placebo for 8 weeks. Severity 
of abdominal pain was assessed with a visual analogue scale (VAS) 
at each visit and a quality-of-life IBS (QoL-IBS) questionnaire was 
also completed.
Results. Eighty-one participants were randomised. There was no 
significant difference in abdominal pain relief between the study and 
placebo groups (p=0.800). There was also no difference in QoL-IBS 
scores between the groups (p=0.687). Both groups had a significant 
improvement in abdominal pain scores from an average of 251.55 to 
197.90 (p<0.0001) over the study period, indicating a large placebo effect.
Conclusion. An 8-week treatment with L. plantarum 299v did not 
provide symptomatic relief, particularly of abdominal pain and 
bloating, in patients fulfilling the Rome II Criteria.
Predicting poor-outcome Crohn’s Disease at 
the time of first diagnosis
G Watermeyer, S Thomson, L Myer
University of Cape Town, Cape Town, South Africa
Background. Most patients with Crohn’s disease (CD) develop 
complications such as strictures or fistulas over time, resulting in 
hospitalisation and surgery. Timely therapy with immunomodulators 
and biologicals may alter this natural history but carries a risk of side-
effects. 
Objective. To identify predictive factors at diagnosis for poor-outcome 
CD to identify those who would most benefit from early, aggressive 
medical therapies.
Methods. A retrospective analysis of 120 CD patients with follow-
up exceeding 5 years was performed using two different definitions 
of poor-outcome CD: disabling CD within 5 years of diagnosis 
(DCD) and severe CD over the entire disease course (SCD). Clinical, 
demographic, laboratory and biological factors at diagnosis associated 
with these outcomes were evaluated by univariate and multivariate 
analysis.
Results. Within 5 years, 72% (86/120) of patients developed DCD; 
on multivariate analysis, perianal disease (odd’s ratio (OR) 11.0; 95% 
confidence interval (CI) 1.1 - 94.7; p=0.03) and ileal involvement (OR 
5.4; 95% CI 2.1 - 13.9; p<0.001) were predictive. Overall 38% (45/120) 
developed SCD and on multivariate survival analysis penetrating 
behaviour (hazard ratio (HR) 2.9; 95% CI 1.2 - 7.0; p=0.02), 
stricturing behaviour (HR 4.6, 95% CI 1.5 - 14.6; p=0.01), perianal 
disease (HR 3.4; 95% CI 1.6 - 7.2; p=0.01) and biopsy granulomas 
(HR 2.4; 95% CI 1.3 - 4.6; p=0.01) were independently associated 
with time to development of SCD. When analysis was restricted to 
non-stricturing/non-penetrating disease, perianal CD and tissue 
granulomas remained strongly associated with SCD with a specificity 
of 99% and a positive predictive value of 89%.
Conclusion. At diagnosis, factors predictive of subsequent SCD in our 
referral centre were stricturing or penetrating phenotype, perianal 
disease and tissue granulomas.
Cold snare polypectomy for colonic polyps >10 mm
I Berkowitz, G Mbuli
Milpark Hospital, Johannesburg, South Africa
Background. Cold polypectomy has been widely used for the removal 
of sub-centimetre colonic polyps. The technique appears to be both 
effective and safe and eliminates the risk of electrocautery. We report 
3 cases of flat colonic polyps >10 mm, which were removed by cold 
snare polypectomy.
Methods. Flat colonic polyps >10 mm were identified on colonoscopy 
in 3 patients. Two patients had polyps on the right side of the colon and 
1 on the left side. The polyps were removed by cold snare polypectomy 
using an Exacto cold snare. One of the polyps was removed completely 
and the other 2 were removed piecemeal. The polyps were retrieved by 
suctioning into a snare trap, for histology.
Results. All 3 patients had their polyps successfully removed by cold 
snare polypectomy, with no complications, such as perforation or 
bleeding. Polyp removal was assessed to be complete with no residual 
polyp seen on careful endoscopic inspection.
Conclusion. Cold snare polypectomy appears to be both feasible and 
safe for the removal of polyps >10 mm in size, either by complete or 
piecemeal removal.
Bile duct perforation in an infant
S Bisetty, M H Sheik Gafoor, V G Naidoo
University of KwaZulu-Natal, Durban, South Africa
Background. Bile duct perforation can present with cholestasis. Less than 
150 cases have been described worldwide and it is often misdiagnosed.
Case presentation. A 4-month-old infant was referred with problems 
of cholestasis and ascites. Biliary atresia was excluded. Histology 
from a laparoscopic liver biopsy was in keeping with a diagnosis of 
neonatal hepatitis. However, despite adequate therapy, the ascites 
worsened. The infant failed to thrive and was emaciated. Repeat 
liver biopsy was normal. The ascitic fluid was re-aspirated and 
bile stained fluid was drained. The plasma bilirubin levels were 
normal. A hepatobiliary iminodiacetic acid (HIDA) isotope scan 
demonstrated normal liver uptake and normal gall bladder filling, 
followed by extravasation of isotope from the extra-hepatic bile duct 
into the peritoneal space. Endoscopic retrograde cholangiography 
demonstrated a bile duct perforation. A stent could not be deployed 
across the defect and a portoenterostomy procedure was performed.
Discussion. It is unclear whether the bile duct injury was due to 
spontaneous bile duct perforation (SBDP) or bile duct trauma from 
the initial liver biopsy. SBDP is the second most common surgical 
cause for cholestasis.
Conclusion. Bile duct perforation, if left undiagnosed and untreated, 
is potentially fatal. One needs to have a high index of suspicion, 
in correlation with the clinical signs and symptoms. A HIDA scan 
proved valuable in defining and localising the clinical problem.
Assessment of the critical flicker frequency measuring 
machine in diagnosis of minimal hepatic encephalopathy
A Deshpande, R Borse
BJ Medical College, Pune, Maharashtra, India
Objectives. To assess the usefulness of a self-designed machine in 
measuring critical flicker frequency (CFF) for diagnosis of minimal 
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hepatic encephalopathy (MHE), exploring cheaper alternatives for 
the diagnosis of MHE.
Methods. All patients with liver disease in Sassoon General Hospital 
in Pune, India over a period of 1 year were considered. Patients with 
liver disease but normal neurological examination participated in 
the study. Patients with overt hepatic encephalopathy (HE) or history 
of HE were excluded. Also patients with any overt neurological or 
ocular diseases were excluded. The number connection tests (NCT) 
A and B were considered standard for diagnosing MHE. All such 
patients were then exposed to the CFF measuring machine and 
readings were taken. Four such readings were obtained in one 
sitting and the average was calculated. Thirty-three patients fitting 
the criteria were diagnosed with MHE and considered for study. 
Most of the patients were encountered in the gastroenterology 
outpatients department (OPD) of the hospital. The control group 
(n=35) consisted of subjects with similar educational status as 
patients, including relatives.
Results. There were 33 subjects with MHE (mean 43.67 years; 
male:female ratio 31:2). There was a negative correlation between 
the NCTs and CFF. The difference between the CFF values of 
the two groups was significant. Correlations between different tests 
were calculated by Spearman’s rank-order correlation coefficient. A 
significance level of p=0.05 was used in all analyses.
Conclusion. This study concluded that the machine under consideration 
could effectively measure CFF and help in diagnosis of MHE in an 
OPD setting. The cost of development was US$73.53 (Rs.4 000), which 
is affordable in various setups.
Duodenal eosinophil count in patients with 
functional dyspepsia at Chris Hani Baragwanath 
Academic Hospital
M Hussein, R Ally, N Chopdat, W AbulHassan, B Bobat
University of the Witwatersrand, Johannesburg, South Africa
Objective. To determine the duodenal eosinophil count in patients 
presenting with functional dyspepsia.
Methods. Patients presenting to the endoscopy unit for an upper 
gastrointestinal (GI) endoscopy were screened using a questionnaire 
and those who satisfied the Rome III Criteria for functional 
dyspepsia were included in the study. An upper GI endoscopy was 
done and patients who had any structural lesions were excluded. 
Recruitment continued consecutively until a sample size of 50 
patients was attained. Three duodenal biopsies from the first part 
of the duodenum were taken to the laboratory to check for the total 
eosinophil count per 5 high power field (HPF).
Results. A total of 50 duodenal biopsies were done of which 3 
had insufficient tissue sample for an eosinophil count and 7 were 
abnormal (i.e. had histopathological features of duodenitis). Forty 
biopsies were taken for the final analysis. The average age of the 
patients was 38  years and 85% were female. Thirty-two patients 
presented with early satiety, 27 with post-prandial bloating, 31 
with abdominal fullness and 36 with epigastric pain syndrome. 
The mean duodenal eosinophil count was 35.6 (standard deviation 
±17.8) per 5  HPF; 70% had an above normal eosinophil count 
(>22 per 5 HPF).
Conclusion. Patients presenting with functional dyspepsia have a high 
duodenal eosinophil count. Randomised placebo-controlled clinical 
trials on anti-eosinophilic agents as treatment for functional dyspepsia 
need to be carried out.
Resistant Clostridium difficile infection and faecal 
transplantation in patients with inflammatory bowel 
disease at Wits Donald Gordon Medical Centre
K Karlsson, P Barrow
Donald Gordon Medical Centre, University of the Witwatersrand, 
Johannesburg, South Africa
Objective. To describe our method and experience with faecal 
transplantation in treating patients with inflammatory bowel disease 
(IBD) and resistant Clostridium difficile infection.
Methods. We treated 3 patients – 1 inpatient due to disease severity 
and associated complications and 2 outpatients. Two failed both 
metronidazole and vancomycin, 1 failed metronidazole and was unable 
to purchase vancomycin. We chose the cheapest and easiest method 
of transplantation for our patients. This entailed commencement of a 
proton pump inhibitor (PPI) 24 hours pre-transplant, discontinuation 
of antibiotics the night before the procedure. Donors were willing to 
donate; history and examination confirmed no significant GI disease. 
Screening included: HIV; hepatitis B and C; stool for ova, cysts, 
parasites; culture; C. difficile polymerase chain reaction (PCR); and, 
in 1 donor, rota and adenoviruses. Donors were prescribed 1 sachet 
of Movicol for the day prior to donation and stool was kept cool 
during transportation. Stool was mixed using a liquidiser with sterile 
water until an acceptable consistency was reached and 50 ml of the 
resulting solution was drawn into a syringe. A nasogastric (NG) tube 
was placed and the position checked by auscultation and aspiration 
of gastric juices. The stool solution was instilled via the NG tube. The 
NG tube was flushed with 50 ml water and left in situ for 15 min. The 
patient was kept for a further 15 - 30 min to ensure emesis did not 
occur. Stool was tested for C. difficile PCR at 4 weeks.
Results. All patients had a successful response with clearance of 
C. difficile and resolution of symptoms.
Conclusion. Faecal transplantation is a successful treatment option 
for recurrent C. difficile infection in patients with IBD.
Adult nesidioblastosis: A problematic diagnosis 
and a treatment challenge
E Loots, F Anderson
Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Natal, 
Durban, South Africa
Background. Nesidioblastosis is an uncommon cause of hyperinsulinaemic 
hypoglycaemia and can significantly impact on quality of life. The 
condition refers to β-cell hyperplasia of the pancreas. The diagnosis is 
difficult to determine. Treatment requires medical and surgical therapies.
Methods. A retrospective chart review was undertaken of all patients 
diagnosed with adult nesidioblastosis between January 2007 and May 
2013. Biochemistry results, radiological reports, histological data 
and operative notes were collected and reviewed. Data were analysed 
using simple statistical methods.
Results. Four patients fulfilled the clinical and histological criteria for the 
diagnosis of nesidioblastosis. Medical therapy using optimal dosages of 
diazoxide failed to control symptoms in all of these patients rendering 
surgery necessary. The pertinent investigations and surgical outcomes 
are summarised in the table. Hypoglycaemia resolved in all patients after 
the initial resection. Three of four patients required further surgery after 
an average of 28 months for recurrence of hypoglycaemia.
Conclusion. The diagnosis of adult nesidioblastosis is difficult to 
make. Current localisation investigations proved unreliable. Medical 
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treatment with diazoxide has limited effect. Recurrent hypoglycaemia 
is not uncommon following initial pancreatic resection and diabetes 
mellitus after repeat surgery.
Normal values of 24-hour ambulatory oesophageal 
multichannel intraluminal impedance-pH 
monitoring in a rural black African population
E J Ndebia, A Sammon, E Umapathy, J Iputo
Walter Sisulu University, Mthatha, South Africa
Background. Impedance-pH monitoring is a new technique for the 
diagnosis of gastro-oesophageal reflux disease (GERD). This method 
detects liquid, mixed and gas reflux as well as its distribution, composition 
and clearing. There is no available data on oesophageal impedance 
monitoring in black African rural populations. 
Objective. To define the normal pattern of gastro-oesophageal reflux of 
rural black Africans and compare them with similar studies.
Methods. Healthy volunteers were recruited and underwent 24-hour 
ambulatory multichannel intraluminal impedance-pH (MII-pH) 
monitoring. Gastro-oesophageal reflux episodes were detected and 
characterised by pH as acid, weakly acid or non-acid reflux and by 
composition as liquid and mixed reflux.
Results. Sixty-four participants were included in the study (16 males, 48 
females). Mean age was 36 years (range 18 - 60). The median and the 
95th percentile of the total reflux episodes was 37 and 82, respectively 
of which acidic, weakly acidic and non-acid reflux were median and 
95th percentile 14 and 59, 12 and 46, and 2 and 20, respectively. The 
composition of the total reflux was 7 and 24 for liquid, 28 and 73 
for mixed and 33 and 135 for gas reflux, respectively. The median 
bolus clearance was 16 s whereas acid was chemically cleared in 54 s. 
More reflux was observed in the upright position while there was an 
increased alkaline reflux compared with similar Western studies.
Conclusion. This study demonstrates that it feasible to carry out an 
impedance-pH monitoring study in rural Africa, and that this provides 
normal values.
‘Downhill’ oesophageal varices
S Onyango,1,2 VG Naidoo,1 KA Newton1
1  University of KwaZulu-Natal, Durban, South Africa
2  Kenyatta National Hospital, Nairobi, Kenya
Background. ‘Downhill’ varices occur when superior vena cava (SVC) 
obstruction results in reversal of blood flow in the upper oesophageal 
venous plexus. ‘Downhill’ varices are usually asymptomatic with few 
cases of bleeding reported.
Case presentation. A 46-year-old Indian female on chronic 
haemodialysis was referred for endoscopy to evaluate persistent 
reflux symptoms. Physical examination revealed distended veins over 
the chest wall and a right subclavian haemodialysis catheter. There 
were no clinical features of cirrhosis and none of the traditional risk 
factors for cirrhosis were identified. Upper endoscopy showed a single 
variceal column in the proximal oesophagus with two short columns 
of varices at the distal oesophagus. No other endoscopic abnormalities 
were seen. Computed axial tomography with pulmonary angiography 
(CT-PA) showed a thrombus at the catheter tip in the SVC. Imaging 
also demonstrated a normal liver outline, normal portal vein and 
no significant splenomegaly. These findings led us to conclude that 
the varices were not due to portal hypertension (‘uphill’) but rather 
related to the SVC obstruction leading to the formation of ‘downhill’ 
varices.
Discussion. The incidental finding of varices in the absence of other 
features of portal hypertension should prompt suspicion of ‘downhill’ 
varices. Awareness of this condition may avoid unnecessary tests 
for liver disease. Bypassing the vascular obstruction is an additional 
therapeutic strategy to consider in those with bleeding ‘downhill’ 
varices.
Conclusion. This case serves to highlight the entity of ‘downhill’ 
varices.
Untreated hypopituitarism-causing cirrhosis in adulthood
N Parsoo,1,2 V G Naidoo,1,2 K A Newton,1,2
1  Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Natal, 
Durban, South Africa
2  Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 
Durban, South Africa
Background. Hypopituitarism is a rare cause of liver disease. It results 
in varying degrees of cholestasis, which may progress to cirrhosis.
Case presentation. A 24-year-old woman with short stature was 
referred for evaluation of abnormal liver function tests. She was 
being investigated for hypopituitarism. Her only complaint was that 
of amenorrhoea. Her developmental history included obstructed 
labour and non-development of secondary sexual characteristics. 
Examination revealed jaundice, proportional short stature with no 
dysmorphic features. She had absent secondary sexual characteristics 
and no signs of chronic liver disease. No splenomegaly or ascites 
were found. Right upper limb Erb’s palsy was present. Biochemistry 
showed a cholestatic hepatitis. Investigations for the aetiology of the 
liver disease were negative. Pituitary profile documented reduced 
growth hormone, cortisol, and sex hormone levels. She had a 
normal 46, XX karyotype. A hypoplastic pituitary was confirmed on 
magnetic resonance imaging. Endoscopic cholangiography revealed 
a non-obstructed biliary system with a paucity of intrahepatic ducts 
and no features of sclerosing cholangitis. Endoscopy confirmed 
oesophageal varices and portal hypertensive gastropathy. Liver biopsy 
showed cirrhosis. A diagnosis of hypopituitary-associated cirrhosis 
was made.
Discussion. Hypopituitarism may be accompanied by progressive 
cholestasis and cirrhosis if hormone replacement is delayed. Hormone 
deficiency may delay maturation of biliary transport mechanisms 
leading to bile accumulation, cholestasis with hepatitis and eventually 
cirrhosis.
Conclusion. It is important for paediatricians, endocrinologists and 
gastroenterologists to be aware of this association, as early initiation 
of hormone replacement may prevent patients from developing 
cirrhosis.
Patient Localisation LA Initial resection Outcome
1 CST + 80% DP GI
2 EUS + CST - 70% DP, recurrence 95% DP, 
DM
3 PET + CST - 40% DP, recurrence 80% DP, 
DM
4 CST - 40% DP, recurrence 80% DP, 
DM
LA= localisation accuracy; CST = calcium stimulation test; DP= distal pancreatectomy;  
GI = glucose intolerant; EUS = endoscopic ultrasound; PET = positron emission tomography; 
DM = diabetes mellitus. 
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Successful pregnancy on anti-TNF-α therapy
JH Van Zyl, WM Simmonds
University Of The Free State, Bloemfontein, South Africa
Background. Female patients with active inflammatory bowel 
disease (IBD) often have difficulties with fertility. They also have 
great concerns regarding the safety of the drugs that are being 
used to treat their disease during pregnancy. Meta-analysis of the 
drugs used for the treatment of IBD show that none of these drugs 
are regarded as being absolutely safe in pregnancy. Anti-tumour 
necrosis factor (TNF) α therapy has been shown to be effective in 
inducing remission. Case reports are being published on successful 
pregnancies on anti-TNF-α therapy.
Case report. A 30-year-old women presented to us during 2008 with a 
history of fistulating Crohn’s disease since 2004. Therapy at that stage 
consisted of 40  mg/d corticosteroids and 150 mg/d azathioprine. 
Metronidazole was stopped a year previously. On examination it was 
found that she had active disease with a rectal fistula and a Crohn’s 
disease Activity Index (CDAI) of 184. Metronidazole was added to 
her therapy but in 2 months the CDAI only dropped to 132. The 
family also paid a visit to the fertility clinic because of concerns 
regarding pregnancy and fertility. Anti-TNF-α therapy was started 
with infliximab (IFX) at a dose of 5 mg/kg in combination with 
100  mg/d azathioprine. Corticosteroids were weaned and stopped. 
The patient’s CDAI dropped to 94. A year after starting therapy with 
IFX a normal pregnancy ensued and a healthy baby boy was delivered 
in March 2010. Due to difficult venous access, IFX was changed 
to adalumimab, 40 mg every 2 weeks. Azathioprine remained at 
100  mg/d. Her CDAI dropped to 52. During 2011 she became 
pregnant again. The pregnancy was uncomplicated and in July 2012 
a healthy baby girl was delivered. The patient’s CDAI at present is 29.
Discussion. Anti-TNF-α therapy in combination with azathioprine in 
this patient: (i) induced remission, (ii) normalised fertility and (iii) 
proved to be safe during pregnancy.
